Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FCQ0P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,408
Award facts
- Contract value 100% obligated
- $11,407.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,407.98 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within Department of Defense healthcare systems, including support for military personnel and veteran care programs.
This delivery order is executed under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The contract structure reflects DLA's reliance on AmerisourceBergen as a primary vendor for pharmaceutical supply chain requirements supporting military healthcare operations worldwide, with flexibility to accommodate varied and recurring medical supply needs across the federal health system.
Quick answers
Who was awarded contract SPE2DR26FCQ0P?
SPE2DR26FCQ0P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FCQ0P worth?
The government has obligated $11,408 on SPE2DR26FCQ0P.
Is contract SPE2DR26FCQ0P an order under another contract?
Yes. SPE2DR26FCQ0P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCQ0P competed?
The extent of competition for SPE2DR26FCQ0P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award